Dataset Information

Discovery of the First Potent Inhibitors of Mutant IDH1 That Lower Tumor 2-HG in Vivo.

ABSTRACT: Optimization of a series of R132H IDH1 inhibitors from a high throughput screen led to the first potent molecules that show robust tumor 2-HG inhibition in a xenograft model. Compound 35 shows good potency in the U87 R132H cell based assay and ?90% tumor 2-HG inhibition in the corresponding mouse xenograft model following BID dosing. The magnitude and duration of tumor 2-HG inhibition correlates with free plasma concentration.

SUBMITTER: Popovici-Muller J

PROVIDER: S-EPMC4025665 | biostudies-literature | 2012 Oct

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Discovery of the First Potent Inhibitors of Mutant IDH1 That Lower Tumor 2-HG in Vivo.

Popovici-Muller Janeta J Saunders Jeffrey O JO Salituro Francesco G FG Travins Jeremy M JM Yan Shunqi S Zhao Fang F Gross Stefan S Dang Lenny L Yen Katharine E KE Yang Hua H Straley Kimberly S KS Jin Shengfang S Kunii Kaiko K Fantin Valeria R VR Zhang Shunan S Pan Qiongqun Q Shi Derek D Biller Scott A SA Su Shinsan M SM

ACS medicinal chemistry letters 20120917 10

Optimization of a series of R132H IDH1 inhibitors from a high throughput screen led to the first potent molecules that show robust tumor 2-HG inhibition in a xenograft model. Compound 35 shows good potency in the U87 R132H cell based assay and ∼90% tumor 2-HG inhibition in the corresponding mouse xenograft model following BID dosing. The magnitude and duration of tumor 2-HG inhibition correlates with free plasma concentration. ...[more]

PMID: 24900389

Dataset Information

Discovery of the First Potent Inhibitors of Mutant IDH1 That Lower Tumor 2-HG in Vivo.

Publications

Discovery of the First Potent Inhibitors of Mutant IDH1 That Lower Tumor 2-HG in Vivo.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Similar Datasets

Discovery of AG-120 (Ivosidenib): A First-in-Class Mutant IDH1 Inhibitor for the Treatment of IDH1 Mutant Cancers.
| S-EPMC5900343 | biostudies-literature

Structure based discovery of clomifene as a potent inhibitor of cancer-associated mutant IDH1.
| S-EPMC5546478 | biostudies-literature

Mutant IDH1 Promotes Glioma Formation In Vivo.
| S-EPMC6032974 | biostudies-literature

ZEB1 expression is increased in IDH1-mutant lower-grade gliomas.
| S-EPMC6088798 | biostudies-literature

Discovery of pan-Histone Acetyltransferase Inhibitors with Potent Antitumor Activity in vivo
2017-10-03 | GSE104522 | GEO

Pan-mutant-IDH1 inhibitor BAY1436032 is highly effective against human IDH1 mutant acute myeloid leukemia in vivo.
| S-EPMC5629366 | biostudies-literature

Discovery of Potent Benzolactam IRAK4 Inhibitors with Robust in Vivo Activity.
| S-EPMC7073891 | biostudies-literature

Inhibition of mutant IDH1 decreases D-2-HG levels without affecting tumorigenic properties of chondrosarcoma cell lines.
| S-EPMC4494954 | biostudies-literature

Discovery of the First Potent and Selective Inhibitors of Human dCTP Pyrophosphatase 1.
| S-EPMC4753678 | biostudies-literature

Discovery and in Vivo Evaluation of Potent Dual CYP11B2 (Aldosterone Synthase) and CYP11B1 Inhibitors.
| S-EPMC4027133 | biostudies-other